Novo Nordisk A/S (NVO) Yield on Cost (YOC): 4.14%
The yield on cost (YOC) for Novo Nordisk A/S (NVO) is 4.14%.
NVO Yield on Cost (YOC) Metrics
YIELD ON COST (YOC)
4.14%
Yield on Cost for NVO
NVO now pays $1.80 per share a year. Measured against the price it actually traded at back then, a long-term holder is earning:
| If you bought | Price then | Yield on cost today |
|---|---|---|
| 10 years ago(2016-06-14) | $26.06 | 6.91% |
| 5 years ago(2021-06-10) | $42.38 | 4.25% |
| 3 years ago(2023-06-12) | $79.38 | 2.27% |
| 1 year ago(2025-06-16) | $77.02 | 2.34% |
| Buying today(at $43.55) | $43.55 | 4.14% |
If you buy today and the dividend keeps growing
Projection: starting from today's 4.14% yield, assuming the dividend keeps compounding at its historical 10.6% rate. Boards set dividends each year, so actual figures will differ.
Today
4.14%
In 3 years
6.29%
In 5 years
8.33%
In 10 years
16.76%
Yield on Cost Calculator
Try your own purchase price, dividend and growth rate for Novo Nordisk A/S (NVO).
Starting Yield
4.13%
Ending YOC
18.68%
Year 15 Dividend
$8.14
Cum. Dividends Recd.
$66.22
| Year | Projected Div. / Share | YoY Dividend Hike | Yield on Cost (YOC) | Total Dividends Recd. |
|---|---|---|---|---|
| Initial | $1.80 | — | 4.13% | $0.00 |
| Year 1 | $1.99 | +10.58% | 4.57% | $1.99 |
| Year 2 | $2.20 | +10.58% | 5.05% | $4.19 |
| Year 3 | $2.43 | +10.58% | 5.59% | $6.63 |
| Year 4 | $2.69 | +10.58% | 6.18% | $9.32 |
| Year 5 | $2.98 | +10.58% | 6.83% | $12.29 |
| Year 6 | $3.29 | +10.58% | 7.56% | $15.58 |
| Year 7 | $3.64 | +10.58% | 8.36% | $19.22 |
| Year 8 | $4.02 | +10.58% | 9.24% | $23.25 |
| Year 9 | $4.45 | +10.58% | 10.22% | $27.70 |
| Year 10 | $4.92 | +10.58% | 11.30% | $32.62 |
| Year 11 | $5.44 | +10.58% | 12.49% | $38.06 |
| Year 12 | $6.02 | +10.58% | 13.82% | $44.08 |
| Year 13 | $6.65 | +10.58% | 15.28% | $50.73 |
| Year 14 | $7.36 | +10.58% | 16.89% | $58.09 |
| Year 15 | $8.14 | +10.58% | 18.68% | $66.22 |
Novo Nordisk A/S Yield on Cost (YOC) Formula & Definition
Yield on cost is the dividend yield measured against your original purchase price, not today's price. As a company raises its dividend, the yield on what you actually paid keeps rising even when the market yield holds steady.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Novo Nordisk A/S Yield on Cost (YOC) FAQ
- What is the yield on cost (YOC) for Novo Nordisk A/S (NVO)?
- The yield on cost (YOC) for NVO stock is 4.14%.
About Novo Nordisk A/S
Novo Nordisk A/S is a global pharmaceutical firm dedicated to the investigation, creation, manufacturing, and distribution of medicinal products across a vast international footprint. Its market presence extends throughout Europe, the Middle East, Africa, various parts of Asia (including Mainland China, Hong Kong, and Taiwan), and North America. The company's operations are structured into two principal business units: Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity Care division delivers therapies for diabetes, obesity, cardiovascular ailments, and other emerging therapeutic areas. Meanwhile, the Rare Disease division concentrates on providing treatments for rare blood disorders, uncommon endocrine conditions, and hormone replacement solutions. In addition to its core pharmaceutical offerings, Novo Nordisk produces specialized medical equipment such as insulin pens, growth hormone pens, and injection needles. It also pioneers smart digital solutions for diabetes management, including advanced insulin pens and the Dose Check application, designed to guide insulin dosage. The company engages in strategic alliances, notably a partnership with UNICEF to combat childhood obesity and a collaboration with Valo Health, Inc. to discover and advance novel drug pipelines in the cardiometabolic space. Founded in 1923, Novo Nordisk A/S is headquartered in Bagsvaerd, Denmark.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- CEO
- Maziar Mike Doustdar